Export terminé — 
Chargement en cours...

Slope of change in HbA(1c) from baseline with empagliflozin compared with sitagliptin or glimepiride in patients with type 2 diabetes

AIMS: To analyse the effect of baseline glycated haemoglobin (HbA(1c)) on the reduction in HbA(1c) with empagliflozin compared with sitagliptin or glimepiride in patients with type 2 diabetes. MATERIALS AND METHODS: Using regression analyses of individual patient data from two Phase III studies, we...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Endocrinol Diabetes Metab
Auteurs principaux: DeFronzo, Ralph A., Ferrannini, Ele, Schernthaner, Guntram, Hantel, Stefan, Elsasser, Ulrich, Lee, Christopher, Hach, Thomas, Lund, Søren S.
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2018
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6354821/
https://ncbi.nlm.nih.gov/pubmed/30815552
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/edm2.16
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!